Carlotz Inc
Change company Symbol lookup
Select an option...
LOTZ Carlotz Inc
TSLA Tesla Inc
INN Summit Hotel Properties Inc
NCNO nCino Inc
FISK Empire State Realty OP LP
RMD Resmed Inc
BST BlackRock Science and Technology Trust
MPW Medical Properties Trust Inc
UWHR Uwharrie Capital Corp
ESI Element Solutions Inc
Go

Consumer Discretionary : Specialty Retail |
Company profile

CarLotz, Inc., formerly Acamar Partners Acquisition Corp., operates vehicle consignment and retail remarketing business. The Company provides its corporate vehicle sourcing partners and retail sellers of used vehicles with the ability to access the retail sales channel. It operates a technology-enabled buying, sourcing and selling model that offers an omni-channel and selection of vehicles, while allowing for an end-to-end electronic commerce interface that enables buying and selling. The Company's Retail Remarketing technology provides its corporate vehicle sourcing partners with real-time performance metrics and data analytics, along with custom business intelligence reporting that enables price and vehicle triage optimization between the wholesale and retail channel. The Company offers its products and services to corporate vehicle sourcing partners, retail sellers of used vehicles and retail customers seeking to buy used vehicles.

Closing Price
$1.80
Day's Change
-0.13 (-6.74%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.04
Day's Low
1.80
Volume
(Heavy Day)
Volume:
1,687,334

10-day average volume:
1,276,528
1,687,334

Final Days to Participate in Spectrum Pharmaceuticals, Inc. (SPPI) Class Action - Bronstein, Gewirtz & Grossman, LLC

11:00 am ET October 29, 2021 (BusinessWire) Print

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Spectrum Pharmaceuticals, Inc. ("Spectrum" or the "Company") (NASDAQ: SPPI) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Spectrum securities between December 27, 2018 and August 5, 2021, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/sppi.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) the manufacturing facility of ROLONTIS (eflapegrastim), a long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia, maintained deficient controls and/or procedures; (2) the foregoing deficiencies decreased the likelihood that the U.S. Food and Drug Administration ("FDA") would approve the ROLONTIS Biologics License Application (the "ROLONTIS BLA") in its current form; (3) Spectrum had therefore materially overstated the ROLONTIS BLA's approval prospects; and (4) as a result, the Company's public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/sppi or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Spectrum you have until November 1, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211029005001/en/

SOURCE: Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 | info@bgandg.com
comtex tracking

COMTEX_396049557/1006/2021-10-29T11:00:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.